{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:21:34Z","timestamp":1795072894063,"version":"4.10.2"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The insulin-like growth factor 1 (IGF-1)-AKT-mTOR pathways sense the availability of nutrients and mitogens and respond by signaling for cell growth and division. The p53 pathway senses a variety of stress signals which will reduce the fidelity of cell growth and division, and responds by initiating cell cycle arrest, senescence, or apoptosis. This study explores four p53-regulated gene products, the \u03b21 and \u03b22 subunits of the AMPK, which are shown for the first time to be regulated by the p53 protein, TSC2, PTEN, and IGF-BP3, each of which negatively regulates the IGF-1-AKT-mTOR pathways after stress. These gene products are shown to be expressed under p53 control in a cell type and tissue-specific fashion with the TSC2 and PTEN proteins being coordinately regulated in those tissues that use insulin-dependent energy metabolism (skeletal muscle, heart, white fat, liver, and kidney). In addition, these genes are regulated by p53 in a stress signal\u2013specific fashion. The mTOR pathway also communicates with the p53 pathway. After glucose starvation of mouse embryo fibroblasts, AMPK phosphorylates the p53 protein but does not activate any of the p53 responses. Upon glucose starvation of E1A-transformed mouse embryo fibroblasts, a p53-mediated apoptosis ensues. Thus, there is a great deal of communication between the p53 pathway and the IGF-1-AKT and mTOR pathways. [Cancer Res 2007;67(7):3043\u201353]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-4149","type":"journal-article","created":{"date-parts":[[2007,4,4]],"date-time":"2007-04-04T20:32:35Z","timestamp":1175718755000},"page":"3043-3053","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":572,"title":["The Regulation of AMPK \u03b21, TSC2, and PTEN Expression by p53: Stress, Cell and Tissue Specificity, and the Role of These Gene Products in Modulating the IGF-1-AKT-mTOR Pathways"],"prefix":"10.1158","volume":"67","author":[{"given":"Zhaohui","family":"Feng","sequence":"first","affiliation":[{"name":"1Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Hu","sequence":"additional","affiliation":[{"name":"1Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Stanchina","sequence":"additional","affiliation":[{"name":"2Cold Spring Harbor Laboratories, Cold Spring Harbor, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika K.","family":"Teresky","sequence":"additional","affiliation":[{"name":"1Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkan","family":"Jin","sequence":"additional","affiliation":[{"name":"1Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Lowe","sequence":"additional","affiliation":[{"name":"2Cold Spring Harbor Laboratories, Cold Spring Harbor, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold J.","family":"Levine","sequence":"additional","affiliation":[{"name":"1Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey;"},{"name":"3School of Natural Sciences, Institute for Advanced Study, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,4,4]]},"reference":[{"key":"2022061623353226500_B1","doi-asserted-by":"crossref","unstructured":"Yoo LI, Chung DC, Yuan J. LKB1\u2014a master tumour suppressor of the small intestine and beyond. Nat Rev Cancer\u20082002; 2: 529\u201335.","DOI":"10.1038\/nrc843"},{"key":"2022061623353226500_B2","doi-asserted-by":"crossref","unstructured":"Levine AJ, Feng Z, Mak TW, You H, Jin S. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev\u20082006; 20: 267\u201375.","DOI":"10.1101\/gad.1363206"},{"key":"2022061623353226500_B3","doi-asserted-by":"crossref","unstructured":"Shaw RJ, Kosmatka M, Bardeesy N, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A\u20082004; 101: 3329\u201335.","DOI":"10.1073\/pnas.0308061100"},{"key":"2022061623353226500_B4","doi-asserted-by":"crossref","unstructured":"Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev\u20082003; 17: 1829\u201334.","DOI":"10.1101\/gad.1110003"},{"key":"2022061623353226500_B5","doi-asserted-by":"crossref","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol\u20082002; 4: 648\u201357.","DOI":"10.1038\/ncb839"},{"key":"2022061623353226500_B6","doi-asserted-by":"crossref","unstructured":"Kamada Y, Sekito T, Ohsumi Y. Autophagy in yeast: a TOR-mediated response to nutrient starvation. Curr Top Microbiol Immunol\u20082004; 279: 73\u201384.","DOI":"10.1007\/978-3-642-18930-2_5"},{"key":"2022061623353226500_B7","doi-asserted-by":"crossref","unstructured":"Lum JJ, Bauer DE, Kong M, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell\u20082005; 120: 237\u201348.","DOI":"10.1016\/j.cell.2004.11.046"},{"key":"2022061623353226500_B8","doi-asserted-by":"crossref","unstructured":"Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, Schreiber SL. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature\u20081995; 377: 441\u20136.","DOI":"10.1038\/377441a0"},{"key":"2022061623353226500_B9","doi-asserted-by":"crossref","unstructured":"Brunn GJ, Hudson CC, Sekulic A, et al. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science\u20081997; 277: 99\u2013101.","DOI":"10.1126\/science.277.5322.99"},{"key":"2022061623353226500_B10","doi-asserted-by":"crossref","unstructured":"Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev\u20082004; 18: 1926\u201345.","DOI":"10.1101\/gad.1212704"},{"key":"2022061623353226500_B11","doi-asserted-by":"crossref","unstructured":"Hannan KM, Brandenburger Y, Jenkins A, et al. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol Cell Biol\u20082003; 23: 8862\u201377.","DOI":"10.1128\/MCB.23.23.8862-8877.2003"},{"key":"2022061623353226500_B12","doi-asserted-by":"crossref","unstructured":"Thomas G. The S6 kinase signaling pathway in the control of development and growth. Biol Res\u20082002; 35: 305\u201313.","DOI":"10.4067\/S0716-97602002000200022"},{"key":"2022061623353226500_B13","doi-asserted-by":"crossref","unstructured":"Downward J. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol\u20082004; 15: 177\u201382.","DOI":"10.1016\/j.semcdb.2004.01.002"},{"key":"2022061623353226500_B14","doi-asserted-by":"crossref","unstructured":"Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell\u20081999; 96: 857\u201368.","DOI":"10.1016\/S0092-8674(00)80595-4"},{"key":"2022061623353226500_B15","doi-asserted-by":"crossref","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science\u20082005; 307: 1098\u2013101.","DOI":"10.1126\/science.1106148"},{"key":"2022061623353226500_B16","doi-asserted-by":"crossref","unstructured":"Plas DR, Thompson CB. Akt-dependent transformation: there is more to growth than just surviving. Oncogene\u20082005; 24: 7435\u201342.","DOI":"10.1038\/sj.onc.1209097"},{"key":"2022061623353226500_B17","doi-asserted-by":"crossref","unstructured":"Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol\u20082003; 5: 578\u201381.","DOI":"10.1038\/ncb999"},{"key":"2022061623353226500_B18","doi-asserted-by":"crossref","unstructured":"Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM. A reversible, p53-dependent G0\/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev\u20081996; 10: 934\u201347.","DOI":"10.1101\/gad.10.8.934"},{"key":"2022061623353226500_B19","doi-asserted-by":"crossref","unstructured":"Saito S, Yamaguchi H, Higashimoto Y, et al. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem\u20082003; 278: 37536\u201344.","DOI":"10.1074\/jbc.M305135200"},{"key":"2022061623353226500_B20","doi-asserted-by":"crossref","unstructured":"Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell\u20082003; 3: 577\u201387.","DOI":"10.1016\/S1535-6108(03)00134-X"},{"key":"2022061623353226500_B21","doi-asserted-by":"crossref","unstructured":"Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ\u20082006; 13: 1027\u201336.","DOI":"10.1038\/sj.cdd.4401910"},{"key":"2022061623353226500_B22","doi-asserted-by":"crossref","unstructured":"Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A\u20082005; 102: 8204\u20139.","DOI":"10.1073\/pnas.0502857102"},{"key":"2022061623353226500_B23","doi-asserted-by":"crossref","unstructured":"Jones RG, Plas DR, Kubek S, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell\u20082005; 18: 283\u201393.","DOI":"10.1016\/j.molcel.2005.03.027"},{"key":"2022061623353226500_B24","doi-asserted-by":"crossref","unstructured":"Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A\u20082003; 100: 15077\u201382.","DOI":"10.1073\/pnas.2436255100"},{"key":"2022061623353226500_B25","doi-asserted-by":"crossref","unstructured":"Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest\u20082003; 112: 1809\u201320.","DOI":"10.1172\/JCI20039"},{"key":"2022061623353226500_B26","doi-asserted-by":"crossref","unstructured":"de Stanchina E, McCurrach ME, Zindy F, et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev\u20081998; 12: 2434\u201342.","DOI":"10.1101\/gad.12.15.2434"},{"key":"2022061623353226500_B27","doi-asserted-by":"crossref","unstructured":"Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature\u20081993; 362: 847\u20139.","DOI":"10.1038\/362847a0"},{"key":"2022061623353226500_B28","doi-asserted-by":"crossref","unstructured":"el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet\u20081992; 1: 45\u20139.","DOI":"10.1038\/ng0492-45"},{"key":"2022061623353226500_B29","doi-asserted-by":"crossref","unstructured":"Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J. The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci U S A\u20082002; 99: 8467\u201372.","DOI":"10.1073\/pnas.132268899"},{"key":"2022061623353226500_B30","doi-asserted-by":"crossref","unstructured":"Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab\u20082005; 1: 15\u201325.","DOI":"10.1016\/j.cmet.2004.12.003"},{"key":"2022061623353226500_B31","doi-asserted-by":"crossref","unstructured":"Warden SM, Richardson C, O'Donnell J, Jr., Stapleton D, Kemp BE, Witters LA. Post-translational modifications of the \u03b2-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem J\u20082001; 354: 275\u201383.","DOI":"10.1042\/bj3540275"},{"key":"2022061623353226500_B32","doi-asserted-by":"crossref","unstructured":"Chen X, Ko LJ, Jayaraman L, Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev\u20081996; 10: 2438\u201351.","DOI":"10.1101\/gad.10.19.2438"},{"key":"2022061623353226500_B33","doi-asserted-by":"crossref","unstructured":"Pochampally R, Fodera B, Chen L, Lu W, Chen J. Activation of an MDM2-specific caspase by p53 in the absence of apoptosis. J Biol Chem\u20081999; 274: 15271\u20137.","DOI":"10.1074\/jbc.274.21.15271"},{"key":"2022061623353226500_B34","doi-asserted-by":"crossref","unstructured":"Li J, Jiang P, Robinson M, Lawrence TS, Sun Y. AMPK-\u03b21 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression. Carcinogenesis\u20082003; 24: 827\u201334.","DOI":"10.1093\/carcin\/bgg032"},{"key":"2022061623353226500_B35","doi-asserted-by":"crossref","unstructured":"Stambolic V, MacPherson D, Sas D, et al. Regulation of PTEN transcription by p53. Mol Cell\u20082001; 8: 317\u201325.","DOI":"10.1016\/S1097-2765(01)00323-9"},{"key":"2022061623353226500_B36","doi-asserted-by":"crossref","unstructured":"Sheng X, Koul D, Liu JL, Liu TJ, Yung WK. Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region. Biochem Biophys Res Commun\u20082002; 292: 422\u20136.","DOI":"10.1006\/bbrc.2002.6662"},{"key":"2022061623353226500_B37","doi-asserted-by":"crossref","unstructured":"Horton LE, Bushell M, Barth-Baus D, Tilleray VJ, Clemens MJ, Hensold JO. p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation. Oncogene\u20082002; 21: 5325\u201334.","DOI":"10.1038\/sj.onc.1205662"},{"key":"2022061623353226500_B38","doi-asserted-by":"crossref","unstructured":"Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature\u20082000; 408: 307\u201310.","DOI":"10.1038\/35042675"},{"key":"2022061623353226500_B39","unstructured":"Fei P, Bernhard EJ, El-Deiry WS. Tissue-specific induction of p53 targets in vivo. Cancer Res\u20082002; 62: 7316\u201327."},{"key":"2022061623353226500_B40","doi-asserted-by":"crossref","unstructured":"Bouvard V, Zaitchouk T, Vacher M, et al. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1\/p21, before and following ionising irradiation in mice. Oncogene\u20082000; 19: 649\u201360.","DOI":"10.1038\/sj.onc.1203366"},{"key":"2022061623353226500_B41","doi-asserted-by":"crossref","unstructured":"Dornan D, Wertz I, Shimizu H, et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature\u20082004; 429: 86\u201392.","DOI":"10.1038\/nature02514"},{"key":"2022061623353226500_B42","doi-asserted-by":"crossref","unstructured":"Leng RP, Lin Y, Ma W, et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell\u20082003; 112: 779\u201391.","DOI":"10.1016\/S0092-8674(03)00193-4"},{"key":"2022061623353226500_B43","doi-asserted-by":"crossref","unstructured":"Buckbinder L, Talbott R, Velasco-Miguel S, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature\u20081995; 377: 646\u20139.","DOI":"10.1038\/377646a0"},{"key":"2022061623353226500_B44","doi-asserted-by":"crossref","unstructured":"Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H. Cell cycle regulation via p53 phosphorylation by a 5\u2032-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-\u03b2-d-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun\u20082001; 287: 562\u20137.","DOI":"10.1006\/bbrc.2001.5627"},{"key":"2022061623353226500_B45","doi-asserted-by":"crossref","unstructured":"Damalas A, Kahan S, Shtutman M, Ben-Ze'ev A, Oren M. Deregulated \u03b2-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J\u20082001; 20: 4912\u201322.","DOI":"10.1093\/emboj\/20.17.4912"},{"key":"2022061623353226500_B46","doi-asserted-by":"crossref","unstructured":"Zindy F, Williams RT, Baudino TA, et al. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proc Natl Acad Sci U S A\u20082003; 100: 15930\u20135.","DOI":"10.1073\/pnas.2536808100"},{"key":"2022061623353226500_B47","doi-asserted-by":"crossref","unstructured":"Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene\u20082005; 24: 2899\u2013908.","DOI":"10.1038\/sj.onc.1208615"},{"key":"2022061623353226500_B48","doi-asserted-by":"crossref","unstructured":"Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature\u20082005; 436: 725\u201330.","DOI":"10.1038\/nature03918"},{"key":"2022061623353226500_B49","doi-asserted-by":"crossref","unstructured":"Freeman DJ, Li AG, Wei G, et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell\u20082003; 3: 117\u201330.","DOI":"10.1016\/S1535-6108(03)00021-7"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/7\/3043\/2580608\/3043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/7\/3043\/2580608\/3043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:09:30Z","timestamp":1655424570000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/7\/3043\/534546\/The-Regulation-of-AMPK-1-TSC2-and-PTEN-Expression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2007,4,4]]},"published-print":{"date-parts":[[2007,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-4149","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496587","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496587.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22370922.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370922","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370919.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370919","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,1]]}}}